GE Capital Provides $6MM Facility to Delphinus Medical Tech
GE Capital, Healthcare Financial Services, said it is serving as administrative agent and sole lender on a $6 million senior secured multi-draw term loan for Delphinus Medical Technologies. The company intends to use the financing primarily for clinical and early commercialization efforts.
“GE delivered extremely competitive financing that met our needs directly,” said William Greenway, CEO of Delphinus Medical Technologies. “They also impressed us with their ability to move quickly through the process and close a complex transaction in a short timeframe.”
“Utilizing our industry and finance expertise, we customized financing that aligned with Delphinus’ short and long-term capital needs,” said Anthony Storino, senior managing director, GE Capital, Healthcare Financial Services, Life Sciences. “We will continue to work closely with Delphinus as they move down the path of developing and commercializing their innovative technology.”